Press Releases | DEA.gov
Pasar al contenido principal
U.S. flag

Un sitio oficial del Gobierno de Estados Unidos

Así es como usted puede verificarlo

Dot gov
Los sitios web oficiales usan .gov
Un sitio web .gov pertenece a una organización oficial del Gobierno de Estados Unidos.
Https

Los sitios web seguros .gov usan HTTPS
Un candado ( Candado Un candado cerrado ) o https:// significa que usted se conectó de forma segura a un sitio web .gov. Comparta información sensible sólo en sitios web oficiales y seguros.

  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contáctenos
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
      • Fee Waiver
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Recibir Actualizaciones
  • Scam Alert
  • Menú Completo
  • English
  • Español

Main Menu

Explore DEA
  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
    • DEA Museum
    • Wall of Honor
    • Contáctenos
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas

Press Releases

Advanced Search

Enter Keywords Below

Filter Results

Select To Narrow Search Results

Year

  • 2026 (1)
  • 2025 (5)
  • 2023 (7)
  • 2022 (12)
  • 2021 (15)
  • 2003 (1)

Subject

  • Drug Trafficking (240)
  • Synthetic drugs (189)
  • Seizures (Drugs/Property) (185)
  • Task Forces/Task Force Officers (169)
  • Major Law Enforcement Operation (129)
  • Guns/Weapons (101)
  • OCDETF/Task Force (85)
  • Overdose (72)
  • Fake Pills (64)
  • Arrests/Convictions - Major (61)
  • Prescription Drugs (55)
  • Gangs (48)
  • Narcoterrorism (38)
  • Diversion Division (36)
  • Guilty Plea (34)
  • Outreach/Drug Prevention (28)
  • Take Back Day (25)
  • Fentanyl Awareness (23)
  • Press Conferences (21)
  • Money Laundering (20)
  • One Pill Can Kill (14)
  • HIDTA (9)
  • Public and Media Affairs - also see Congressional Affairs (9)
  • Dark Web- Internet Trafficking (8)
  • Prevention/Education - DEA websites GSAD, JTT etc (7)
  • International/Foreign Operations (6)
  • Asset Forfeiture (5)
  • Fentanyl Free America (4)
  • Counterfeit Pills (3)
  • Extraditions (3)
  • Campaigns (2)
  • Intergovernmental Affairs (2)
  • Museum and Visitors Center (2)
  • Cartel (1)
  • Congressional Affairs (1)
  • Intelligence Division - Intelligence Products (1)
  • Red Ribbon (1)
  • Terrorism (1)
  • Pharmaceuticals/Pharmacists/Physicians (41)

Drug Name

  • Opioids (25)
  • Oxycodone (11)
  • Synthetic Opioids (10)
  • Fentanyl (7)
  • Hydromorphone (6)
  • Benzodiazepines (3)
  • Morphine (3)
  • Steroids (3)
  • Cocaine (1)
  • Heroin (1)
  • Methadone (1)
  • Methamphetamine (1)

Field Division

  • St. Louis (32)
  • New York (21)
  • Chicago (19)
  • Miami (16)
  • Atlanta (12)
  • New Jersey (11)
  • El Paso (10)
  • Seattle (9)
  • Sede (9)
  • Dallas (8)
  • Houston (7)
  • San Francisco (7)
  • New England (5)
  • San Diego (5)
  • Los Angeles (4)
  • New Orleans (4)
  • Rocky Mountain (3)
  • Omaha (2)
  • Phoenix (2)
  • Philadelphia (1)
  • Washington, DC (35)
  • Louisville (6)
Clear All Results
41 Results - Showing 1 to 10
PRESS RELEASE

DEA Issues Immediate Suspension Order to Kentucky Pharmaceutical Distributor Over Controlled Substances Act Violations

LOUISVILLE, Ky. – Earlier today, the U.S. Drug Enforcement Administration issued an Immediate Suspension Order (ISO) to Richie Pharmacal, a pharmaceutical distributor in Glasgow, Kentucky. An ISO is an emergency administrative action that immediately suspends a DEA registrant's authority to handle controlled substances, due to imminent danger to public health...
PRESS RELEASE

Clay County Pharmacy Investigation and Prosecution Ends in Guilty Pleas

NASHVILLE – Thomas K. Weir, 65, majority owner of Oakley Pharmacy d/b/a Dale Hollow Pharmacy and Clay County Xpress Pharmacy (“Xpress Pharmacy”); William L. Donaldson, 65, former owner and pharmacist of Dale Hollow Pharmacy (then known as Donaldson Pharmacy); and Pamela Spivey, 55, co-owner of Xpress Pharmacy (all of Celina...
PRESS RELEASE

Putnam County Veterinarian Ordered to Pay $956,709 in Civil Penalties

CHARLESTON, W.Va. – The United States Attorney’s Office for the Southern District of West Virginia secured a $956,709 default judgment against Clara Ann Mason, a Putnam County veterinarian, after she was unable to account for 9,796 dosage units of oxycodone HCL, hydrocodone/acetaminophen and other controlled substances, Acting United States Attorney...
PRESS RELEASE

2025 National Health Care Fraud Takedown

ALEXANDRIA, Va. – Erik S. Siebert, U.S. Attorney for the Eastern District of Virginia, announced criminal charges against six defendants. The charges filed in federal court are part of the Department of Justice’s 2025 National Health Care Fraud Takedown . The charges are part of a strategically coordinated, nationwide law...
PRESS RELEASE

Franklin, Kentucky Pharmacist and Spouse Sentenced to Federal Prison

Louisville, KY – Last week, a Franklin, Kentucky, pharmacist was sentenced to 3 years in federal prison and his wife was sentenced to 2 years in federal prison for engaging in a conspiracy to commit theft of medical products, conspiracy to unlawfully distribute controlled substances, conspiracy to commit health care...
PRESS RELEASE

Three Convicted for Fraudulently Billing Over $8 Million to Medicare and Medicaid Through Opioid Addiction Treatment Clinics in Kentucky

A federal jury convicted a Kentucky doctor, a Texas businessman, and a Kentucky woman for their roles operating a scheme out of a series of addiction treatment facilities in Kentucky that fraudulently billed Medicare and Kentucky Medicaid for over $8 million. The verdict was handed down on Thursday, March 20...
PRESS RELEASE

DEA Washington Division is Ready to Celebrate the 25th National Drug Take Back Day Across the DMV

Washington, DC – The Drug Enforcement Administration (DEA) will host its 25th National Prescription Drug Take Back Day on Saturday, October 28, from 10 a.m. to 2 p.m. in more than 300 collection sites across Maryland, District of Columbia, and Virginia (DMV). Through a collaborative effort with local law enforcement...
PRESS RELEASE

Former Chief Operating Officer of Area Pain Clinics Indicted

CHARLOTTESVLLE, Va. – A federal grand jury returned an indictment this week charging the former chief operating officer of area pain clinics with three conspiracy counts for her alleged involvement in health care fraud and illegal drug distribution. Jennifer Ann “Jen” Adams, 50, of Mount Pleasant, South Carolina, is charged...
PRESS RELEASE

Consent Decree Approved Among the U.S. and Cumberland, M.D. based Pharmacy and Pharmacist

Baltimore, Maryland - U.S. District Judge Lydia K. Griggsby approved the United States’ consent decree with John A. Beckman, a Cumberland, Maryland based pharmacist, and Beckman’s Greene Street Pharmacy, Inc. (“Beckman’s Pharmacy”), resolving the United States’ civil allegations that Beckman and Beckman’s Pharmacy violated the Controlled Substances Act (“CSA”) in...
PRESS RELEASE

The United States and Montgomery County Based Pharmacy and Pharmacist Reach a Consent Decree Over Allegations of Illegally Dispensed Controlled Substances

Greenbelt, Maryland - U.S. District Judge Peter J. Messitte approved the United States’ consent decree with Abtin Youssefi-Rashti, a Montgomery County based pharmacist, and Upton Care Pharmacy, Inc. (“Upton Care”), resolving the United States’ civil allegations that Youssefi-Rashti and Upton Care violated the Controlled Substances Act (“CSA”) in illegally dispensing...

Paginación

  • Current page 1
  • Page 2
  • Page 3
  • Page 4
  • Page 5
  • Siguiente
  • Última página »
  • Quienes Somos
    • Sobre
    • Contáctenos
    • Museo DEA
  • Recursos
    • Ley de Libertad de Información (FOIA)
    • Publicaciones
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
  • Políticas
    • Accesibilidad, Complementos y Política
    • Políticas Legales y Descargos de Responsabilidad
    • Antidiscriminación y Represalias Acto
    • Política de Privacidad
    • Política de Igualdad de Oportunidades en el Empleo del U.S. DOJ
    • USA.gov
    • Protección de Denunciantes
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000
Contact the Webmaster